Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of 313.75 million as of April 29, 2026. Its market cap has increased by 124.89% in one year.

Market Cap

313.75M

Enterprise Value

322.40M

Revenue

17.81M

Ranking

n/a

PE Ratio

n/a

Stock Price

14.88

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 309.05M to 313.75M, an increase of 1.52%. That is a compound annual growth rate of 0.08%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	313.75M	-34.10%
Dec 30, 2025	476.07M	173.36%
Dec 30, 2024	174.16M	97.16%
Dec 29, 2023	88.33M	219.35%
Dec 30, 2022	27.66M	-4.32%
Dec 30, 2021	28.91M	-24.65%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Santhera Pharmaceuticals Holding AG	235.92M
BioVersys AG	167.25M
Basilea Pharmaceutica AG	651.45M
Xlife Sciences AG	122.85M
Molecular Partners AG	122.34M
Idorsia	945.16M
MindMaze Therapeutics Holding	45.93M
EvoNext Holdings	7.07M

Market Cap Rankings